| [1] |
Chen W, Liu Q, Wang H, et al. Prevalence and risk factors of chronic kidney disease: a population study in the Tibetan population [J]. Nephrol Dial Transplant, 2011, 26(5): 1592-1599.
|
| [2] |
Zhang L, Wang Z, Chen Y, et al. Prevalence and risk factors associated with chronic kidney disease in adults living in 3 different altitude regions in the Tibetan Plateau [J]. Clin Chim Acta, 2018, 481: 212-217.
|
| [3] |
吴晓凡,尹悦,干颖滢,等. 西藏自治区基层卫生资源配置现状及公平性研究[J]. 中国全科医学,2023, 26(16): 1953-1957.
|
| [4] |
刘楠梅,李红仙,赵枢,等. 西藏自治区八宿县农村成年人慢性肾脏病流行病学调查及影响因素分析 [J]. 中国中西医结合肾病杂志,2021, 22(1): 14-18.
|
| [5] |
Jazienicka-Kielb A, Babicki M, Krajewska M, et al. Assessment of primary care physicians′ knowledge of chronic kidney disease in Poland [J]. Front Public Health, 2022, 10: 1032240.
|
| [6] |
Mishina S, Ito Y, Lee T, et al. Physician and patient preferences for treatment of anemia associated with chronic kidney disease in Japan: a survey including best-worst scaling [J]. Patient Prefer Adherence, 2024, 18: 1563-1575.
|
| [7] |
赵振平,王丽敏. 中国慢性肾脏病防控面临的挑战和建议[J]. 中华流行病学杂志,2025, 46(1): 9-17.
|
| [8] |
汤曦,石运莹,王俭勤,等. 中国成人慢性肾脏病及其并发症早期筛查临床路径专家建议(2023版) [J]. 中国实用内科杂志,2023, 43(3): 198-205.
|
| [9] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease [J]. Kidney Int, 2024, 105(4S): S117-S314.
|
| [10] |
中国医师协会肾脏内科医师分会肾性贫血指南工作组. 中国肾性贫血诊治临床实践指南[J]. 中华医学杂志,2021, 101(20): 1463-1502.
|
| [11] |
刘泽,程杨,陶卓霖,等. 西藏自治区层级医疗设施可达性精细化评价[J]. 地理学报,2024, 79(2): 502-514.
|
| [12] |
Liu B, Wang Q, Wang Y, et al. Utilization of antihypertensive drugs among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE) [J]. J Clin Hypertens (Greenwich), 2020, 22(1): 57-64.
|
| [13] |
Mccoy IE, Han J, Montez-Rath ME, et al. Barriers to ACEI/ARB use in proteinuric chronic kidney disease: an observational study [J]. Mayo Clin Proc, 2021, 96(8): 2114-2122.
|
| [14] |
Leon SJ, Whitlock R, Rigatto C, et al. Hyperkalemia-related discontinuation of renin-angiotensin-aldosterone system inhibitors and clinical outcomes in CKD: a population-based cohort study [J]. Am J Kidney Dis, 2022, 80(2): 164-173.e1.
|
| [15] |
Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection [J]. Am J Hematol, 2020, 95(6): E131-E144.
|
| [16] |
阿勇,党宗辉,次仁罗布,等. 西藏地区慢性肾脏病患者贫血现状调查[J]. 中华肾脏病杂志,2016, 32(12): 928-930.
|
| [17] |
Chou CL, Chung CH, Chiu HW, et al. Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3-5 in Taiwan [J]. Sci Rep, 2021, 11(1): 22602.
|
| [18] |
嘎多,张建斌,黄萍,等. 西藏自治区195所医院护理人力资源现况研究[J]. 护理管理杂志,2021, 21(12): 907-909.
|
| [19] |
Lopez-Vargas PA, Tong A, Howell M, et al. Educational interventions for patients with CKD: a systematic review [J]. Am J Kidney Dis, 2016, 68(3): 353-370.
|
| [20] |
Hsu HT, Chiang YC, Lai YH, et al. Effectiveness of multidisciplinary care for chronic kidney disease: a systematic review [J]. Worldviews Evid Based Nurs, 2021, 18(1): 33-41.
|
| [21] |
Santosh R, Mohammed YN, Rahaman Z, et al. The role of telemedicine in enhancing chronic kidney disease (CKD) management and dialysis care [J]. Cureus, 2024, 16(3): e55816.
|
| [22] |
Yang S, Zhao H, Zhang H, et al. Current status and continuing medical education need for general practitioners in Tibet, China: a cross-sectional study [J]. BMC Med Educ, 2024, 24(1): 265.
|
| [23] |
An K, Zhang L, Qiao R, et al. Training needs and curriculum of continuing medical education among general practitioners in Tibet, China: a cross-sectional survey [J]. Front Public Health, 2022, 10: 914847.
|